Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2010-05-19 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references Rule 3.19A.2, which pertains to disclosure of changes in directors' interests in securities. It details specific transactions by a director, including the number of shares/options acquired and disposed, dates of changes, and consideration amounts. The content focuses exclusively on insider share transactions by a company director. There is no financial performance data, earnings information, or report publication details. The document length is 3119 characters, which is relatively short and consistent with a director's dealing notice. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2010-05-19 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed information about a director's transactions in company securities, including dates, number of shares/options held before and after the change, and nature of the transaction. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure related to insider trading or director share dealings. The content is specific to personal share transactions by a company director, which matches the definition of 'Director's Dealing'. The document length is 2886 characters, which is consistent with a detailed notice rather than a full report. Therefore, the appropriate classification is 'DIRS' (Director's Dealing).
2010-05-18 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, prices, and compliance statements. The document is short (2175 characters) and is a regulatory notice about share repurchase activity rather than a full financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2010-05-18 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, prices, and compliance statements. The document is short (2170 characters) and focuses solely on share buy-back activity without financial statements or broader financial performance data. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buyback activities. It is not an announcement of a report, nor a full financial report, so it is not RPA or 10-K. Therefore, the correct classification is POS with high confidence.
2010-05-17 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, prices, and compliance statements. The document is short (2172 characters) and is a regulatory notice about share repurchase activity, not a full financial report or earnings release. This fits the definition of a 'Transaction in Own Shares' filing, which reports company buyback activities.
2010-05-12 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, and compliance statements related to the buy-back. It does not contain financial statements or detailed financial analysis but is a regulatory notice about share repurchase activity. The document length is short (2171 characters) and it is clearly a notice of share buy-back activity, which fits the definition of 'Transaction in Own Shares' (POS).
2010-05-11 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.